German biotech CureVac, which is developing a coronavirus vaccine, has filed for a U.S. IPO, reported Reuters.
Dye & Durham, a portfolio company of Manulife Capital, has secured an additional C$22.5 million from the over-allotment option granted as part of its initial public offering on the Toronto Stock Exchange.
Nextpoint Acquisition Corp, a newly-organized special purpose acquisition corporation, has filed a preliminary prospectus for an initial public offering on the Toronto Stock Exchange
Dye & Durham, a portfolio company of Manulife Capital, has completed its initial public offering and secondary offering in Canada.
PPD, another H&F portfolio company that provides outsourced pharma services, returned to the public markets in February at an initial EV of approximately $14bn.
Deerfield Healthcare Technology Acquisitions Corp, a blank check company that is backed by Deerfield Management Company LP, has debuted its IPO after pricing its 12.5 million shares at $10 per share.
Montrose Environmental Group Inc, an environmental services company, has priced its IPO of 10 million shares at a range between $15 and $17 per share.
GoHealth, a health insurance marketplace, has debuted its IPO after pricing its 43.5 million shares at $21 per share.
Quarterly look of IPO registration and IPO aftermarket of companies to go public that are backed by private equity
Jamf, a software maker for Apple devices, is expected to price its IPO of 16 million shares at a range between $17 and $19 per share.